Efficacy and safety of cabozantinib rechallenge in metastatic renal cell carcinoma: A retrospective multicentric study-Reference-Cited by-同舟云学术

Efficacy and safety of cabozantinib rechallenge in metastatic renal cell carcinoma: A retrospective multicentric study

Published:2023-11 Issue: Volume:193 Page:113292
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Baudry Edwige^ORCID,Naoun Natacha^ORCID,Auclin Edouard^ORCID,Saldana Carolina,Barthelemy Philippe,Geoffrois Lionnel,Thibault Constance,de Vries-Brilland Manon,Borchiellini Delphine,Maillet Denis,Hirsch Laure,Vauchier Charles,Carril-Ajuria Lucia^ORCID,Colomba Emeline,Bernard-Tessier Alice^ORCID,Escudier Bernard,Flippot Ronan,Albigès Laurence

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference25 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Renal cell tumors: understanding their molecular pathological epidemiology and the 2016 WHO classification;Inamura;IJMS,2017

3. Renal cell carcinoma;Hsieh;Nat Rev Dis Primers,2017

4. Recommandations françaises du Comité de cancérologie de l′AFU – actualisation 2020–2022: prise en charge du cancer du rein;Bensalah;Progrès en Urologie,2020

5. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma;Motzer;N Engl J Med,2007

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of Factors Contributing to Adverse Events and Evaluation of Their Impact on Prognosis in Metastatic Renal Cell Carcinoma Patients—Real-World Experience in a Single-Center Retrospective Study and Narrative Review;Medicina;2024-02-26